Takeda Takes Stake, Inks Deal With Newly Launched Izana Bioscience Post author:Sam Post published:December 13, 2017 Post category:BioPharma As part of the licence agreement, Takeda has taken a strategic equity stake in Izana. Source: BioSpace You Might Also Like <b>ISPE</b> Releases The New Cultural Excellence Report May 7, 2017 Why This Connecticut Biotech Could be a $1M Opportunity for Investors January 23, 2018 Multiple Myeloma Research Foundation (MMRF) Announces $15 Million Investment In Immunotherapy Initiative June 28, 2017
Multiple Myeloma Research Foundation (MMRF) Announces $15 Million Investment In Immunotherapy Initiative June 28, 2017
